Allergan, Kissei Settle With Sandoz In Prostate Drug Suit
Kissei Pharmaceutical and Allergan reached an agreement to dismiss all claims against Sandoz in litigation alleging the Novartis division infringed a patent for their enlarged-prostate medication Rapaflo by seeking approval for...To view the full article, register now.
Already a subscriber? Click here to view full article